top of page

PRP vs. Steroid Injections for Sciatica and Low Back Pain: What the Research Shows

  • 5 days ago
  • 6 min read

Written by Dr. Jeffrey Peng, MD — Board-Certified Sports Medicine Physician

Published: March 1, 2026 | Last Updated: March 1, 2026


Platelet-rich plasma (PRP) injections are increasingly marketed as a natural, regenerative treatment for sciatica and low back pain — promising to reduce inflammation, promote tissue healing, and provide lasting relief without the downsides of steroids. But does the science actually support these claims? A brand-new systematic review and meta-analysis directly compared PRP injections to corticosteroid epidural injections for lumbar radiculopathy, and the findings may surprise you. In this article, I break down what the latest research tells us about PRP for sciatica, how it compares to steroid injections, and what you should know before considering either option.


Watch the Full Video



What Is Lumbar Radiculopathy (Sciatica)?


Lumbar radiculopathy — commonly known as sciatica — is caused by compression or irritation of a spinal nerve, often due to a herniated disc or spinal stenosis. It typically results in sharp, shooting pain that radiates down the leg, sometimes accompanied by numbness, tingling, or weakness. In my practice, this is one of the most common conditions I see in patients with low back and leg pain.


Most cases of sciatica improve with conservative treatment, including medications, physical therapy, and activity modification. However, when symptoms persist, many spine specialists turn to epidural steroid injections, which deliver anti-inflammatory medication directly to the irritated nerve root. While these injections can offer meaningful short-term relief, their long-term benefits are limited — prompting growing interest in alternatives like platelet-rich plasma (PRP).


How Does PRP Work for Spinal Conditions?


PRP is created by drawing a patient's own blood, spinning it in a centrifuge, and isolating the platelets — tiny cell fragments packed with growth factors. These growth factors are believed to reduce inflammation and support tissue repair, including around irritated spinal nerves. A comprehensive review by Fang et al., 2020 in Tissue Engineering Part B: Reviews outlined the regenerative potential of PRP across a wide range of orthopedic injuries, highlighting its abundant growth factors and cytokines as key mediators of tissue healing.


The appeal is clear: a natural, drug-free alternative to corticosteroids that might do more than just mask symptoms — it might actually promote healing. PRP has shown promise in conditions like knee osteoarthritis and tendon injuries, but whether it is effective for nerve-related back pain has remained uncertain until recently.


What Did the Latest Meta-Analysis Find?


A 2025 systematic review and meta-analysis published in the Journal of Orthopaedic Surgery and Research by Wang & Zhang, 2025 pooled data from seven studies — including four randomized controlled trials and three prospective studies — comparing PRP injections to corticosteroids for lumbar radiculopathy. In total, the analysis included over 400 patients with MRI-confirmed nerve root compression from conditions like disc herniation or spinal stenosis.


Researchers evaluated two primary outcomes — pain intensity (using the Visual Analog Scale) and functional disability (using the Oswestry Disability Index) — at 4 weeks, 3 months, and 6 months after treatment. Here is what they found:


At the 4-week mark, corticosteroid injections outperformed PRP when it came to improving function. Patients who received steroids showed significantly better ODI scores, meaning they were more mobile and less disabled in daily life. However, when it came to pain relief, there was no meaningful difference between the two treatments at any time point — not at 4 weeks, 3 months, or 6 months.


Interestingly, by the 6-month follow-up, PRP showed a slight trend toward better functional outcomes, but the difference was not statistically significant. As for safety, both treatments were well tolerated. Minor side effects like transient pain or mild muscle weakness were rare and resolved on their own. No serious complications were reported in either group.


Do Other Studies Support These Findings?


A separate meta-analysis of five randomized controlled trials by Muthu et al., 2025 in Experimental Biology and Medicine reached a similar conclusion: epidural PRP injections offered comparable pain relief, functional improvement, and overall health outcomes as epidural steroid injections at all observed time points, with no increase in adverse events. This reinforces the idea that PRP is not dramatically better or worse than steroids for this indication — at least based on the current evidence.


One notable double-blind randomized trial by Saraf et al., 2023 in the Indian Journal of Orthopaedics did find a more encouraging signal for PRP. In their study of 60 patients, the steroid group performed better at 1 month, both groups were comparable at 3 months, and the PRP group showed significantly better pain and disability scores at 6 months. Over 90% of PRP patients had a negative straight leg raise test at 6 months, compared to just 62% in the steroid group. This suggests PRP may offer more sustained benefits, though larger studies are needed to confirm this pattern.


Additionally, a prospective study by Le et al., 2022 in the Asian Journal of Surgery demonstrated that transforaminal PRP injections produced statistically significant improvements in pain (VAS), disability (ODI), and straight leg raise testing sustained over 12 months of follow-up, with no complications reported.


Limitations of the Current Evidence


While the data so far is informative, it is important to acknowledge significant limitations. There was considerable variation across studies in how PRP was prepared — including differences in platelet concentration, injection volume, activation methods, and delivery technique (transforaminal vs. interlaminar). This variability makes it difficult to draw firm conclusions about the "best" PRP protocol for spinal conditions.


Sample sizes across the included studies were relatively small, follow-up periods were generally limited to 6 months or less, and not all studies were high quality. Importantly, none of these studies included a true placebo (sham injection) group, which means we cannot rule out the possibility that both treatments simply benefited from the natural course of the condition or a placebo effect.


Should You Get PRP for Sciatica?


If you are dealing with sciatica and looking for fast, proven relief, epidural steroid injections remain the more reliable first-line choice. They reduce inflammation quickly and can help restore mobility within weeks. This is particularly relevant for patients who need rapid functional improvement to participate in physical therapy or return to work.


PRP may sound appealing because it is autologous (derived from your own blood) and potentially regenerative, but the current evidence does not show that it works better than corticosteroids — especially in the short term. PRP is also typically more expensive, less widely available, and highly variable in how it is prepared and delivered across different clinics.


That said, if you are unable to tolerate corticosteroids (for example, due to diabetes or repeated steroid use), or if you are looking for longer-term options after exhausting standard treatments, PRP may still have a role in your care. In my practice, I discuss PRP as one of several tools in the treatment toolkit — not as a miracle solution, but as a reasonable option worth considering in the right clinical context. The most important step is to have a thorough evaluation with a physician who can review your imaging, assess your symptoms, and help you weigh the risks and benefits of each approach.



References


Wang X, Zhang Y. Therapeutic interventions of platelet-rich plasma versus corticosteroid injections for lumbar radicular pain: a systematic review and meta-analysis. J Orthop Surg Res. 2025;20(1):306. https://doi.org/10.1186/s13018-025-05725-z


Muthu S, Viswanathan VK, Gangadaran P. Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials. Exp Biol Med (Maywood). 2025;250:10390. https://doi.org/10.3389/ebm.2025.10390


Saraf A, Hussain A, Sandhu AS, Bishnoi S, Arora V. Transforaminal injections of platelet-rich plasma compared with steroid in lumbar radiculopathy: a prospective, double-blind randomized study. Indian J Orthop. 2023;57(7):1126-1133. https://doi.org/10.1007/s43465-023-00898-3


Le VT, Nguyen Dao LT, Nguyen AM. Transforaminal injection of autologous platelet-rich plasma for lumbar disc herniation: a single-center prospective study in Vietnam. Asian J Surg. 2022;46(1):438-443. https://doi.org/10.1016/j.asjsur.2022.05.047


Fang J, Wang X, Jiang W, et al. Platelet-rich plasma therapy in the treatment of diseases associated with orthopedic injuries. Tissue Eng Part B Rev. 2020;26(6):571-585. https://doi.org/10.1089/ten.TEB.2019.0292



Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. The information presented reflects the opinion of the author and is based on current research at the time of publication. Always consult with a qualified healthcare provider before making decisions about your treatment.

Comments


bottom of page